Shenzhen Kangtai Biological Products: Announcement regarding the cancellation of the raised funds account.
Shenzhen Kangtai Biological Products: Announcement on the acceptance of clinical trial application for the quadrivalent influenza virus split vaccine (MDCK cell) of the company.
Shenzhen Kangtai Biological Products: Announcement of interest payment for convertible bonds of the company due in 2024.
Shenzhen Kangtai Biological Products: Announcement on Supplementary Pledge of Part of Shares by Controlling Shareholders and Actual Controllers
Shenzhen Kangtai Biological Products: Announcement of Resolutions of the 22nd Meeting of the 7th Board of Directors.
Shenzhen Kangtai Biological Products: Announcement regarding not adjusting the Kangtai Conversion 2 stock price downwards.
Shenzhen Kangtai Biological Products: Announcement of convertible bond conversion into stocks for the second quarter of 2024.
Shenzhen Kangtai Biological Products: Announcement Regarding the Potential Triggering of Conversion Price Adjustment Conditions for Kangtai Convertible Bonds
Shenzhen Kangtai Biological Products: 2021 Shenzhen Kangtai Biological Products Co., Ltd. issued convertible bonds on the Growth to unspecified objects. The 2024 tracking rating report of the CSI Enterprise Bond Index.
Shenzhen Kangtai Biological Products: Announcement Regarding Shareholding Commitment by the Company's Controlling Shareholder, Actual Controller, Shareholders Holding More Than 5% of Shares, Some Directors, Supervisors, and Senior Management Who Pledged Not to Reduce Shareholding of the Company.
Shenzhen Kangtai Biological Products: Shenzhen Kangtai Biological Products Co., Ltd. issued a trust management report on convertible corporate bonds (2023) to unspecified parties.
Shenzhen Kangtai Biological Products: Shenzhen Kangtai Biological Products Co., Ltd. issued a third interim entrusted management report on convertible corporate bonds to unspecified persons (2024 annual report).
Shenzhen Kangtai Biological Products: Announcement regarding the price adjustment of convertible bond-to-stock conversion.
Shenzhen Kangtai Biological Products: Announcement of Annual Equity Distribution Implementation in 2023
Shenzhen Kangtai Biological Products: Shenzhen Kangtai Biological Products Co., Ltd. issued a second temporary trustee management report (2024) for convertible corporate bonds to unspecified parties.
Shenzhen Kangtai Biological Products: Announcement on the downward revision of the conversion price of convertible corporate bonds
Shenzhen Kangtai Biological Products: Announcement of Resolutions of the 21st Meeting of the 7th Board of Directors
Shenzhen Kangtai Biological Products: Legal Opinion of Guohao Lawyers (Shenzhen) Firm on the 2023 Annual General Meeting of Shareholders of Shenzhen Kangtai Biological Products Co., Ltd.
Shenzhen Kangtai Biological Products: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Shenzhen Kangtai Biological Products: Notice on the change of office address
No Data